-
公开(公告)号:US20160032057A1
公开(公告)日:2016-02-04
申请号:US14773631
申请日:2014-03-11
申请人: NIHON UNIVERSITY
IPC分类号: C08G73/20
CPC分类号: C08G73/20 , C07D403/14 , C07D405/14 , C07D519/00 , C12Q2525/113
摘要: To provide a safe and stable medicine useful for prevention and treatment of prostate cancer.A novel PI polyamide is acquired that recognizes and binds to a specific base sequence of an Oct1 gene binding sequence present in a transcriptional regulatory region (AR response region) of an ACSL3 gene and regulating the transcription activity of AR. This leads to the provision of an ACSL3 gene expression inhibitor and a preventive and/or therapeutic agent of prostate cancer containing the PI polyamide as an active ingredient.
摘要翻译: 提供一种安全稳定的药物,用于预防和治疗前列腺癌。 获得一种新颖的PI聚酰胺,其识别并结合存在于ACSL3基因的转录调控区(AR反应区)中的Oct1基因结合序列的特异碱基序列并调节AR的转录活性。 这导致提供ACSL3基因表达抑制剂和含有PI聚酰胺作为活性成分的前列腺癌的预防和/或治疗剂。